David William Oaks (born September 16, 1955, Chicago) is an American civil rights activist best known for founding and serving as executive director of MindFreedom International, an advocacy group based in Eugene, Oregon. The organization brings together psychiatric survivors, allied clinicians and other advocates to press for changes in how mental health services are delivered and governed. Oaks has been a visible spokesperson for rights-based approaches to mental health care and for greater attention to the harms some people experience from psychiatric treatment.

Mission and positions

MindFreedom International, under Oaks's leadership, has described itself as a coalition that questions the prevailing biomedical model of psychiatry and promotes alternatives centered on human rights, informed consent and peer support. The group includes people who identify as psychiatric survivors as well as clinicians who dissent from mainstream psychiatric practice. Critics and supporters alike recognize the organization for its emphasis on patient autonomy and its critiques of overreliance on medication and coercive practices.Learn more about the organisation.

Activities and priorities

  • Advocacy for informed consent, transparent information about medication risks, and the right to refuse treatment.
  • Promotion of peer-run and noncoercive alternatives to hospitalization and forced treatment.
  • Public education campaigns to highlight adverse effects of psychiatric drugs and promote recovery options that do not depend solely on medication.
  • Networking among survivors, activists and dissident professionals who challenge dominant paradigms in mental health care.

Oaks and his colleagues have framed much of their work as a civil rights effort: arguing that people subjected to involuntary treatment or stigmatizing diagnoses deserve legal protections, respectful care and access to a range of supports. That stance places MindFreedom in a broader international movement sometimes described as the psychiatric survivor movement or consumer/survivor/ex-patient (c/s/x) movement, which overlaps but is distinct from academic critiques of psychiatry.More on participants

Controversies and impact

The questions raised by Oaks and his organization—about drug side effects, restraint and seclusion, electroconvulsive therapy, and the limits of a strictly biomedical framing of emotional distress—are contested in clinical and policy debates. Mainstream psychiatry has criticized some of the movement's claims, while human rights groups and some clinicians acknowledge the importance of centering patient voices. Oaks's work has contributed to ongoing conversations about how to balance clinical perspectives with civil liberties, and about how to expand supports for people in distress beyond a narrow focus on medications and diagnosis.Context on the biomedical model